KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
123 hedge funds and large institutions have $399M invested in Keryx Biopharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 38 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
+7
Holders Change %
+6.03%
% of All Funds
3.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
36
Reduced
38
Closed
12
Calls
$3.06M
Puts
$4.37M
Net Calls
-$1.31M
Net Calls Change
-$776K
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$7.57M |
| 2 |
Millennium Management
New York
|
+$3.51M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.05M |
| 4 |
Morgan Stanley
New York
|
+$1.77M |
| 5 |
Bank of New York Mellon
New York
|
+$1.58M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.09M |
| 2 |
State Street
Boston,
Massachusetts
|
-$3.9M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.54M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$2.87M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.66M |
